The diagnostic value of two commercially available human cTnI assays in goat kids with myocarditis

dc.contributor.authorKarapinar, Tolga
dc.contributor.authorEroksuz, Yesari
dc.contributor.authorHayirli, Armagan
dc.contributor.authorBeytut, Enver
dc.contributor.authorKaynar, Ozgur
dc.contributor.authorBaydar, Ersoy
dc.contributor.authorIsidan, Hakan
dc.date.accessioned2026-08-12T17:16:48Z
dc.date.issued2016
dc.departmentFırat Üniversitesi
dc.description.abstractBackgroundCardiac troponin I (cTnI) is a peripheral blood marker for myocardial damage. Because of the unavailability of goat-specific cTnI assays human cTnI assays may be validated for detection of myocarditis in goat kids. ObjectivesThe purpose of the study was to evaluate 2 commercially available human cTnI assays in goat kids with myocardial damage, and to determine the cTnI expression in cardiac muscle. Materials and MethodsPlasma cTnI concentrations were measured in healthy goat kids (n = 7) and goat kids with myocardial damage (n = 8) using the Beckman Coulter Access Accu TnI and the Biomerieux Vidas Ultra. The results were correlated with gross necropsy and histopathologic findings, and cTnI immunhistochemistry in cardiac tissue. ResultsMacro- and microscopic findings confirmed myocardial damage in the myocarditis group. Mean plasma cTnI concentration was significantly higher in the myocarditis group than in the healthy control group (104.82 vs 0.02 ng/mL). The overall mean plasma cTnI concentration measured by Biomerieux Vidas Ultra (61.75 ng/mL, 95% CI: 19.55-103.95) was comparable to the mean measured by Beckman Coulter Access Accu TnI (50.08 ng/mL, 95% CI: 24.11-76.06), and cTnI concentrations measured by these assays were highly correlated (r = .977) with a -6.2% bias. Both assays were precise and accurate. ConclusionThe human-specific Beckman Coulter Access Accu TnI and the Biomerieux Vidas Ultra can be used for diagnostic confirmation of myocardial damage in caprine medicine.
dc.identifier.doi10.1111/vcp.12328
dc.identifier.endpage171
dc.identifier.issn0275-6382
dc.identifier.issn1939-165X
dc.identifier.issue1
dc.identifier.orcid0000-0002-3712-7991
dc.identifier.orcid0000-0001-5962-8810
dc.identifier.orcid0000-0002-5080-1936
dc.identifier.pmid26802431
dc.identifier.scopus2-s2.0-84958087896
dc.identifier.scopusqualityQ2
dc.identifier.startpage164
dc.identifier.urihttps://doi.org/10.1111/vcp.12328
dc.identifier.urihttps://hdl.handle.net/11508/52426
dc.identifier.volume45
dc.identifier.wosWOS:000372925900019
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherWiley
dc.relation.ispartofVeterinary Clinical Pathology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.subjectBiomarker
dc.subjectcTnI
dc.subjectgoat
dc.subjectmyocardial damage
dc.titleThe diagnostic value of two commercially available human cTnI assays in goat kids with myocarditis
dc.typeArticle

Dosyalar